Summary
The Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022 is a comprehensive bill designed to modernize how the FDA oversees everyday products like cosmetics, dietary supplements, and medical tests. For consumers, the bill’s most direct impact would be stricter safety standards for cosmetics—requiring companies to register their products and report serious side effects—and a new requirement for dietary supplement makers to provide the FDA with a full list of their ingredients. Additionally, the bill aims to lower healthcare costs by speeding up the approval of generic drugs and allowing for the temporary importation of certain prescription drugs from countries like Canada to address high prices and shortages.
AI-generated summary
Lifecycle of the Bill
No events recorded for this stage yet.
No events recorded for this stage yet.
